Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The primary objective of the trial is to evaluate the efficacy and safety of 3 doses of RWJ-333369 (100, 300, and 600 mg per day) vs placebo in the prophylaxis of migraine.
Critère d'inclusion
- Migraine Headaches